Metaplastic carcinoma
Metaplastic carcinoma is a rare type of breast cancer that accounts for less than 1% of all breast cancer cases. It is characterized by the presence of both epithelial and mesenchymal components in the tumor tissue. This type of cancer is known for its aggressive behavior and poor prognosis compared to other types of breast cancer.
Symptoms[edit]
Metaplastic carcinoma may present with symptoms similar to other types of breast cancer, such as a lump or mass in the breast, changes in the size or shape of the breast, skin changes on the breast, nipple discharge, or pain in the breast or nipple.
Diagnosis[edit]
Diagnosis of metaplastic carcinoma is typically made through a combination of imaging tests, such as mammography or ultrasound, and a biopsy of the suspicious tissue. The biopsy will reveal the presence of both epithelial and mesenchymal components in the tumor tissue, confirming the diagnosis of metaplastic carcinoma.
Treatment[edit]
Treatment for metaplastic carcinoma usually involves a combination of surgery, chemotherapy, and radiation therapy. Surgery is often the first line of treatment and may involve a lumpectomy or mastectomy, depending on the size and location of the tumor. Chemotherapy and radiation therapy may be used before or after surgery to help shrink the tumor and reduce the risk of recurrence.
Prognosis[edit]
Metaplastic carcinoma is known to have a poorer prognosis compared to other types of breast cancer. The aggressive nature of this type of cancer can make it more difficult to treat, and the risk of recurrence is higher. However, the prognosis can vary depending on the stage of the cancer at the time of diagnosis and the individual characteristics of the tumor.
Prevention[edit]
There are no specific guidelines for preventing metaplastic carcinoma, as the exact cause of this type of cancer is not well understood. However, maintaining a healthy lifestyle, including regular exercise, a balanced diet, and avoiding known risk factors for breast cancer, such as smoking and excessive alcohol consumption, may help reduce the risk of developing any type of breast cancer.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian